MSVDX | VHCIX | MSVDX / VHCIX | |
Total Expense Ratio | 0.95 | 0.09 | 1,056% |
Annual Report Gross Expense Ratio | 11.44 | 0.09 | 12,711% |
Fund Existence | 3 years | 21 years | - |
Gain YTD | -8.262 | -1.356 | 609% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 100000 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.85M | 17.4B | 0% |
Annual Yield % from dividends | 0.09 | 1.64 | 5% |
Returns for 1 year | -11.40 | -6.14 | 186% |
Returns for 3 years | 1.22 | 13.50 | 9% |
Returns for 5 years | N/A | 34.12 | - |
Returns for 10 years | N/A | 79.11 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRHSX | 77.13 | -0.37 | -0.48% |
T. Rowe Price Health Sciences | |||
WFGDX | 10.55 | -0.14 | -1.31% |
Allspring Emerging Growth Admin | |||
FLRAX | 40.05 | -0.58 | -1.43% |
Nuveen Large Cap Select A | |||
LISOX | 15.71 | -0.23 | -1.44% |
Lazard International Strategic Eq Open | |||
GTTTX | 30.35 | -0.55 | -1.78% |
Goldman Sachs Small Cp Val Insghts Inv |